sequoia capital

Putting His Insignia On The Southeast Asian Tech Startup Scene

An exclusive interview with Tan Yinglan, founding managing partner of Insignia Ventures Partners and ex-Sequoia venture capitalist, on closing his most recent US$120 million funding round.

Newsummit Pharmaceutical Group Partners With Cleveland Bio Fund

China-based Newsummit Pharmaceutical Group and the Cleveland Bio Fund will invest US$100 million in U.S.-based medical device companies that are looking to enter the Chinese market.